Influence of zoledronic acid on disseminated tumor cells in bone marrow and survival: results of a prospective clinical trial

BACKGROUND: The presence of disseminated tumor cells (DTC) in bone marrow (BM) of breast cancer patients is associated with reduced clinical outcome. Bisphosphonate treatment was shown to eradicate DTC from BM in several studies. This controlled randomized open-label multi-center study aimed to inve...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Banys, Malgorzata, Solomayer, Erich-Franz, Gebauer, Gerhard, Janni, Wolfgang, Krawczyk, Natalia, Lueck, Hans-Joachim, Becker, Sven, Huober, Jens, Kraemer, Bernhard, Wackwitz, Birgit, Hirnle, Peter, Wallwiener, Diethelm, Fehm, Tanja
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4015285/
https://ncbi.nlm.nih.gov/pubmed/24128322
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-13-480
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares